AI assistant
Sending…
Royalty Pharma plc — Director's Dealing 2026
Jan 2, 2026
30286_dirs_2026-01-02_6d610ac3-cfd7-4757-9053-f1193d59cd8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2025-12-31
Reporting Person: Bassler Bonnie L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Class A Ordinary Shares | A | 967 | $38.7418 | Acquired | 73132 | Direct |
Footnotes
F1: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.
More from Royalty Pharma plc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13